Jelena Rasic Ozegovic
Research Subjects
Jelena Rasic Ozegovic has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Danijela Ristic-Medic
Group for Nutritional Biochemistry and Dietology; Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
2 shared publications - Marija Takić
Group for Nutrition and Metabolism, Center of Research Excellence for Nutrition and Metabolism, University of Belgrade—Institute for Medical Research, National Institute of Republic of Serbia, Tadeuša Košćuška 1, 11000 Belgrade, Serbia
2 shared publications - Nemanja Rancic
Faculty of Medicine of the Military Medical Academy, University of Defence, 11000 Belgrade, Serbia
2 shared publications - Nevena Ivanović
Department of Bromatology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia
2 shared publications A. Stajić
Department of Drug Analysis, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, Belgrade, Serbia
1 shared publicationB. Djordjevic
University of Belgrade, Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
Gender Differences in Anti-Doping Rule Violations Based on a 19-Year Data Analysis from the Serbian Anti-Doping Agency: National Study
Background: Gender differences in anti-doping rule violations (ADRVs) have been noted in international research, yet systematic analyses are rare. This study addresses that gap by providing the first comprehensive evaluation of the doping prevalence by gender in Serbia. Methods: A 19-year retrospective quantitative analysis was conducted on data collected by the Anti-Doping Agency of Serbia (ADAS) between 2006 and 2024. In total, 14,919 doping controls were performed, including 10,912 (73.11%) on male athletes and 4007 (26.89%) on female athletes. Results: Across this period, 146 ADRVs were identified, with a clear gender imbalance: 128 (87.32%) cases involved male athletes and 18 (12.68%) female athletes. A Chi-Square test confirmed a significant association between gender and ADRVs, χ2(1, N = 14,919) = 15.11, p < 0.001, indicating that male athletes were more likely to violate anti-doping rules. Substance profiles also differed: anabolic agents (S1) dominated overall, while stimulants (S6) and cannabinoids (S8) were more frequent in males, and diuretics (S5) and hormone modulators (S4) in females. Conclusions: These findings reveal a pronounced gender disparity in doping behavior and substance choice, providing a foundation for further research and emphasizing the need for gender-sensitive anti-doping education and policy.
Open AccessGender Differences in Anti-Doping Rule Violations Based on a 19-Year Data Analysis from the Serbian Anti-Doping Agency: National Study
Background: Gender differences in anti-doping rule violations (ADRVs) have been noted in international research, yet systematic analyses are rare. This study addresses that gap by providing the first comprehensive evaluation of the doping prevalence by gender in Serbia. Methods: A 19-year retrospective quantitative analysis was conducted on data collected by the Anti-Doping Agency of Serbia (ADAS) between 2006 and 2024. In total, 14,919 doping controls were performed, including 10,912 (73.11%) on male athletes and 4007 (26.89%) on female athletes. Results: Across this period, 146 ADRVs were identified, with a clear gender imbalance: 128 (87.32%) cases involved male athletes and 18 (12.68%) female athletes. A Chi-Square test confirmed a significant association between gender and ADRVs, χ2(1, N = 14,919) = 15.11, p < 0.001, indicating that male athletes were more likely to violate anti-doping rules. Substance profiles also differed: anabolic agents (S1) dominated overall, while stimulants (S6) and cannabinoids (S8) were more frequent in males, and diuretics (S5) and hormone modulators (S4) in females. Conclusions: These findings reveal a pronounced gender disparity in doping behavior and substance choice, providing a foundation for further research and emphasizing the need for gender-sensitive anti-doping education and policy.
- Open Access
- 6 August 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1625859
Differences in anti-doping knowledge among Serbian professional athletes
Objectives: The aim of this study was to examine the impact of anti-doping education among professional athletes on anti-doping knowledge.Methods: A prospective cohort study was conducted on differences in knowledge toward doping among 404 professional athletes in relation to their education about doping.Results: Participants who underwent education answered correctly significantly more often on most of the questions compared to participants without education [difference of about 20–30% in the rate of correct answers is in favor of participants with education on every question; 8.49 (SD 2.75) vs. 11.04 (SD 1.89); p < 0.001]. The majority of participants in the group with prior education against doping answered 10 or more questions correctly out of a total of 13, while the group without prior education against doping most commonly had 7 to 11 correct answers (p < 0.001). The most significant predictors of correct answers are gender, number of years of training, type of sport (individual or team sport), and prior education about doping. The largest contribution to this model comes from the variable “prior education against doping,” followed by the type of sport.Conclusion: Our research shows that prior anti-doping education is effective and has the essential contribution on athletes’ knowledge about doping.
- 6 August 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1625859
Open AccessDifferences in anti-doping knowledge among Serbian professional athletes
Objectives: The aim of this study was to examine the impact of anti-doping education among professional athletes on anti-doping knowledge.Methods: A prospective cohort study was conducted on differences in knowledge toward doping among 404 professional athletes in relation to their education about doping.Results: Participants who underwent education answered correctly significantly more often on most of the questions compared to participants without education [difference of about 20–30% in the rate of correct answers is in favor of participants with education on every question; 8.49 (SD 2.75) vs. 11.04 (SD 1.89); p < 0.001]. The majority of participants in the group with prior education against doping answered 10 or more questions correctly out of a total of 13, while the group without prior education against doping most commonly had 7 to 11 correct answers (p < 0.001). The most significant predictors of correct answers are gender, number of years of training, type of sport (individual or team sport), and prior education about doping. The largest contribution to this model comes from the variable “prior education against doping,” followed by the type of sport.Conclusion: Our research shows that prior anti-doping education is effective and has the essential contribution on athletes’ knowledge about doping.
- Open Access
- 15 February 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1235, 124047
Urinary excretion profile of higenamine in females after oral administration of supplements – Doping scenario
- 15 February 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1235, 124047
Open AccessUrinary excretion profile of higenamine in females after oral administration of supplements – Doping scenario
- Open Access
- 4 February 2024
- Published by MDPI AG in Proceedings
- Vol. 91 (1) , 213
The Effect of Higenamine Supplementation on the Fatty Acid Profiles of Serum Phospholipids
Background and objectives: Higenamine is an alkaloid found in different plant species like Aconitum japonica, Nandina domestica, Gnetum parvifolium, and Asarum heterotropoides. According to the available data in the literature, its dietary intake leads to an enhancement of lipolysis. The objective of this study was to explore whether the ingestion of a one-component higenamine supplement (75 mg/day) for three weeks would introduce some changes in the fatty acid (FA) profiles of serum phospholipids of female recreational athletes. Methods: A total of 12 female recreational athletes were included in a double-blind study, with six participants in both groups—a higenamine treatment group and placebo group. Serum phospholipids were isolated via one-dimensional thin-layer chromatography. Fatty acid methyl ester samples from the phospholipids were analyzed by a gas–liquid chromatography method. Desaturase and elongase activities were calculated from product/precursor FA ratios. Results: In the group that was undergoing higenamine treatment, a statistically significant increase in the levels of linolenic acid, a total n − 6 polyunsaturated FAs (PUFAs), and an n − 6/n − 3 FA ratio were observed. But saturated palmitic acid and monounsaturated palmitoleic and oleic acid, as well as consequent total saturated FAs and monounsaturated FA acids decreased in serum phospholipids. Also, after 3 weeks of higenamine supplementation, arachidonic n − 6 acid and docosapentaenoic n − 3 acids levels were significantly decreased, and estimated delta-5 desaturase activity (arachidonic/dihomo-gamma-linolenic acid ratio) was decreased too. In the placebo group, a significant change was increased levels of oleic acid compared to baseline levels. Conclusion: According to the results obtained for the FA status of serum phospholipids, treatment with higenamine was followed by a modulation of serum phospholipid FA profiles. Furthermore, this could influence the desaturation/elongation metabolic pathway of endogenous FA metabolisms, leading to a decrease in delta-5 desaturase activity and consequently lower levels of long-chain PUFAs. For further discussion, it is necessary to assess the dietary intake of study participants.
- 4 February 2024
- Published by MDPI AG in Proceedings
- Vol. 91 (1) , 213
Open AccessThe Effect of Higenamine Supplementation on the Fatty Acid Profiles of Serum Phospholipids
Background and objectives: Higenamine is an alkaloid found in different plant species like Aconitum japonica, Nandina domestica, Gnetum parvifolium, and Asarum heterotropoides. According to the available data in the literature, its dietary intake leads to an enhancement of lipolysis. The objective of this study was to explore whether the ingestion of a one-component higenamine supplement (75 mg/day) for three weeks would introduce some changes in the fatty acid (FA) profiles of serum phospholipids of female recreational athletes. Methods: A total of 12 female recreational athletes were included in a double-blind study, with six participants in both groups—a higenamine treatment group and placebo group. Serum phospholipids were isolated via one-dimensional thin-layer chromatography. Fatty acid methyl ester samples from the phospholipids were analyzed by a gas–liquid chromatography method. Desaturase and elongase activities were calculated from product/precursor FA ratios. Results: In the group that was undergoing higenamine treatment, a statistically significant increase in the levels of linolenic acid, a total n − 6 polyunsaturated FAs (PUFAs), and an n − 6/n − 3 FA ratio were observed. But saturated palmitic acid and monounsaturated palmitoleic and oleic acid, as well as consequent total saturated FAs and monounsaturated FA acids decreased in serum phospholipids. Also, after 3 weeks of higenamine supplementation, arachidonic n − 6 acid and docosapentaenoic n − 3 acids levels were significantly decreased, and estimated delta-5 desaturase activity (arachidonic/dihomo-gamma-linolenic acid ratio) was decreased too. In the placebo group, a significant change was increased levels of oleic acid compared to baseline levels. Conclusion: According to the results obtained for the FA status of serum phospholipids, treatment with higenamine was followed by a modulation of serum phospholipid FA profiles. Furthermore, this could influence the desaturation/elongation metabolic pathway of endogenous FA metabolisms, leading to a decrease in delta-5 desaturase activity and consequently lower levels of long-chain PUFAs. For further discussion, it is necessary to assess the dietary intake of study participants.
- Open Access
- 7 September 2021
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 12
Influence of Higenamine on Exercise Performance of Recreational Female Athletes: A Randomized Double-Blinded Placebo-Controlled Trial
The aim of this study was to determine the ergogenic effects and the safety profile of a one-component higenamine supplement in female recreational athletes. Twelve recreational female basketball players (age 29–41 years, oxygen consumption (VO2max) > 30 ml⋅kg–1⋅min–1, with training > 5 h wk–1) were randomized either to the higenamine group, or to the placebo group for 3 weeks. In order to determine ergogenic effects and safety profile of higenamine administration, we assessed the following variables before and after 3 weeks of supplementation: anthropometric parameters, resting metabolic rate (RMR), exercise testing variables, serum free fatty acids (FFAs), blood pressure, enzyme activity, urea, lipid profile, and complete blood count. There were no differences between groups in anthropometric parameters, including basal metabolic rate (BMR), RMR and body fat [p = 0.706 (Cohen’s d 0.223), p = 0.169 (Cohen’s d 0.857), and p = 0.223 (Cohen’s d 0.750), respectively], FFAs [0.43 ± 0.03 vs. 0.54 ± 0.23, p = 0.206 (Cohen’s d 0.540)], neither significant differences in cardiopulmonary parameters after the intervention period. Furthermore, all measured outcome variables in the safety assessment were not significant, with values remaining stable during the intervention period for participants in both groups. This is the first study to document the effects and the safety profile of higenamine-based dietary supplements at a specified dose in female recreational athletes. Our data indicate that 21-day of supplementation with 75 mg higenamine would not result in improving cardiopulmonary exercise fitness and weight loss in female recreational athletes. Moreover, supplementation with 75 mg higenamine is safe and well-tolerated in younger recreational female athletes.
- 7 September 2021
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 12
Open AccessInfluence of Higenamine on Exercise Performance of Recreational Female Athletes: A Randomized Double-Blinded Placebo-Controlled Trial
The aim of this study was to determine the ergogenic effects and the safety profile of a one-component higenamine supplement in female recreational athletes. Twelve recreational female basketball players (age 29–41 years, oxygen consumption (VO2max) > 30 ml⋅kg–1⋅min–1, with training > 5 h wk–1) were randomized either to the higenamine group, or to the placebo group for 3 weeks. In order to determine ergogenic effects and safety profile of higenamine administration, we assessed the following variables before and after 3 weeks of supplementation: anthropometric parameters, resting metabolic rate (RMR), exercise testing variables, serum free fatty acids (FFAs), blood pressure, enzyme activity, urea, lipid profile, and complete blood count. There were no differences between groups in anthropometric parameters, including basal metabolic rate (BMR), RMR and body fat [p = 0.706 (Cohen’s d 0.223), p = 0.169 (Cohen’s d 0.857), and p = 0.223 (Cohen’s d 0.750), respectively], FFAs [0.43 ± 0.03 vs. 0.54 ± 0.23, p = 0.206 (Cohen’s d 0.540)], neither significant differences in cardiopulmonary parameters after the intervention period. Furthermore, all measured outcome variables in the safety assessment were not significant, with values remaining stable during the intervention period for participants in both groups. This is the first study to document the effects and the safety profile of higenamine-based dietary supplements at a specified dose in female recreational athletes. Our data indicate that 21-day of supplementation with 75 mg higenamine would not result in improving cardiopulmonary exercise fitness and weight loss in female recreational athletes. Moreover, supplementation with 75 mg higenamine is safe and well-tolerated in younger recreational female athletes.
- 1 November 2017
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 146, 48-52
Determination of higenamine in dietary supplements by UHPLC/MS/MS method
- 1 November 2017
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 146, 48-52
Determination of higenamine in dietary supplements by UHPLC/MS/MS method